[ad_1]
NEW DELHI, Oct 13 (Reuters) – India’s external affairs minister told his Gambian counterpart on Thursday that New Delhi was investigating the deaths of some children in the African country, after a report provisionally linked the fatalities to a product manufactured in India.
Indian health authorities announced a production halt at Maiden Pharmaceuticals on Wednesday after a WHO report that the company’s cough and cold syrups might be linked to the children’s deaths.
Register now for FREE unlimited access to Reuters.com
Reporting by Tanvi Mehta; editing by John Stonestreet
Our Standards: The Thomson Reuters Trust Principles.
[adinserter block=”4″]
[ad_2]
Source link